SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
IMPAX Laboratories, Inc. and ThoRx Laboratories Confirm Patent Challenge Relating to Generic OPANA® ER 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg